This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Brand Names
- Pneumovax 23, Prevnar 13, Vaxneuvance
- Generic Name
- Streptococcus pneumoniae type 5 capsular polysaccharide antigen
- DrugBank Accession Number
- DB10323
- Background
Streptococcus pneumoniae type 5 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 5 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
- Type
- Biotech
- Groups
- Approved, Investigational
- Biologic Classification
- Vaccines
Other vaccines - Synonyms
- pneumococcal capsular polysaccharide type 5 vaccine
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- N8R9GL539D
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Active Not Recruiting Prevention Invasive Pneumococcal Disease, Protection Against / Pneumococcal Infection / Streptococcus Pneumoniae Infections 1 4 Active Not Recruiting Prevention Plasma Cell Neoplasms 1 4 Active Not Recruiting Prevention Pneumococcal Infection 1 4 Active Not Recruiting Prevention Sepsis 1 4 Completed Basic Science Aging / Pneumonia 1 4 Completed Diagnostic Crohn's Disease (CD) 1 4 Completed Diagnostic Immune Responses / Pneumonia / Streptococcus Pneumoniae 1 4 Completed Prevention Acute Lymphoblastic Leukaemias (ALL) 1 4 Completed Prevention Asthma 2 4 Completed Prevention BCG Infection / Immune Responses / Vaccine Reaction 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intramuscular; Subcutaneous Solution Intramuscular; Subcutaneous Injection, solution Subcutaneous Suspension Intramuscular Injection Intramuscular Injection, suspension Intramuscular Injection - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53